The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease
Open accessAbstract
Alzheimer's disease is a neurodegenerative disorder mainly characterized by β-amyloid deposit and tau hyperphosphorylation with no curative treatments. Curcumin (Cur) has been proved to have potential use in Alzheimer's disease with its anti-amyloid, anti-inflammatory, and anti-oxidant properties, etc. However, its hydrophobicity and low bioavailability hinder its application. In this paper, we designed a novel brain-target nanoparticle, poly(lactide-co-glycolide)-block-poly(ethylene glycol) (PLGA-PEG) conjugated with B6 peptide and was loaded with Cur (PLGA-PEG-B6/Cur) and administered it into HT22 cells and APP/PS1 Al transgenic mice. The in vitro assays including dynamic light scattering (DLS), flow cytometry (FCM), red blood cell (RBC) lysis, and thromboelastography (TEG) analysis indicated that this nanoparticle could narrow the diameter of Cur, increase its cellular uptake and possess good blood compatibility. The results from Morris water maze proved that PLGA-PEG-B6/Cur could tremendously improve the spatial learning and memory capability of APP/PS1 mice, compared with native Cur. The ex vivo assays including Bielschowsky silver staining, immunostaining, and western blotting demonstrated that PLGA-PEG-B6/Cur could reduce hippocampal β-amyloid formation and deposit and tau hyperphosphorylation. Thus, we suggested that PLGA-PEG-B6/Cur nanoparticles would be of potential and promising use for the treatment of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Jain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
Bloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,286
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Shaikh, J., Ankola, D. D., Beniwal, V., Singh, D., & Kumar, M. N. V. R. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.019 · Cited by 956
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 841
Synaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517
Anitha, A., Deepagan, V. G., Divya Rani, V. V., Menon, D., Nair, S. V., & Jayakumar, R. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.01.005 · Cited by 516
REVIEW: Curcumin and Alzheimer’s disease
Hamaguchi, T., Ono, K., & Yamada, M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00147.x · Cited by 450
Mathew, A., Fukuda, T., Nagaoka, Y., Hasumura, T., Morimoto, H., Yoshida, Y., Maekawa, T., Venugopal, K., & Kumar, D. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032616 · Cited by 442
Gong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., Staniszewski, A., Moolman, D., Zhang, H., Shelanski, M., & Arancio, O. (2006) · Cell · doi:10.1016/j.cell.2006.06.046 · Cited by 420
Molecular Pathogenesis of Alzheimer's Disease: An Update
Sanabria-Castro, A., Alvarado-Echeverría, I., & Monge-Bonilla, C. (2017) · Annals of Neurosciences · doi:10.1159/000464422 · Cited by 418
The Stability, Sustained Release and Cellular Antioxidant Activity of Curcumin Nanoliposomes
Chen, X., Zou, L.-Q., Niu, J., Liu, W., Peng, S.-F., & Liu, C.-M. (2015) · Molecules · doi:10.3390/molecules200814293 · Cited by 414
Self-citationKhalil, N. M., Nascimento, T. C. F. D., Casa, D. M., Dalmolin, L. F., Mattos, A. C. D., Hoss, I., Romano, M. A., & Mainardes, R. M. (2013) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2012.06.024 · Cited by 413
Biological and therapeutic activities, and anticancer properties of curcumin
PERRONE, D., ARDITO, F., GIANNATEMPO, G., DIOGUARDI, M., TROIANO, G., LO RUSSO, L., DE LILLO, A., LAINO, L., & LO MUZIO, L. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2749 · Cited by 348
Song, Z., Feng, R., Sun, M., Guo, C., Gao, Y., Li, L., & Zhai, G. (2011) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2010.10.024 · Cited by 340
The Mechanisms of Action of Curcumin in Alzheimer’s Disease
Tang, M., & Taghibiglou, C. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170188 · Cited by 304
Targeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides
Li, J., Feng, L., Fan, L., Zha, Y., Guo, L., Zhang, Q., Chen, J., Pang, Z., Wang, Y., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.031 · Cited by 296
Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
Cummings, J. L., Doody, R., & Clark, C. (2007) · Neurology · doi:10.1212/01.wnl.0000295996.54210.69 · Cited by 279
Curcumin, a Compound from Natural Sources, a True Scientific Challenge – A Review
Stanić, Z. (2017) · Plant Foods for Human Nutrition · doi:10.1007/s11130-016-0590-1 · Cited by 276
Prades, R., Guerrero, S., Araya, E., Molina, C., Salas, E., Zurita, E., Selva, J., Egea, G., López-Iglesias, C., Teixidó, M., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.063 · Cited by 270
Goozee, K. G., Shah, T. M., Sohrabi, H. R., Rainey-Smith, S. R., Brown, B., Verdile, G., & Martins, R. N. (2016) · British Journal of Nutrition · doi:10.1017/s0007114515004687 · Cited by 244
Nanobiotechnology-Based Strategies for Crossing The Blood–Brain Barrier
Jain, K. K. (2012) · Nanomedicine · doi:10.2217/nnm.12.86 · Cited by 233
Rodent models for Alzheimer’s disease drug discovery
Puzzo, D., Gulisano, W., Palmeri, A., & Arancio, O. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1041913 · Cited by 222
Zhao, L., Du, J., Duan, Y., Zang, Y., Zhang, H., Yang, C., Cao, F., & Zhai, G. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2012.04.017 · Cited by 216
Yin, T., Yang, L., Liu, Y., Zhou, X., Sun, J., & Liu, J. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.06.035 · Cited by 197
Self-citationComparison of five different targeting ligands to enhance accumulation of liposomes into the brain
van Rooy, I., Mastrobattista, E., Storm, G., Hennink, W. E., & Schiffelers, R. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.014 · Cited by 188
Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits
Jiao, S.-S., Yao, X.-Q., Liu, Y.-H., Wang, Q.-H., Zeng, F., Lu, J.-J., Liu, J., Zhu, C., Shen, L.-L., Liu, C.-H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422998112 · Cited by 174
Self-citationGraphene quantum dots conjugated neuroprotective peptide improve learning and memory capability
Xiao, S., Zhou, D., Luan, P., Gu, B., Feng, L., Fan, S., Liao, W., Fang, W., Yang, L., Tao, E., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.021 · Cited by 169 · cited 1×
“We followed the procedures as described (Xiao et al., 2016; Chen et al., 2017).”
Self-citationB6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide
Liu, Z., Gao, X., Kang, T., Jiang, M., Miao, D., Gu, G., Hu, Q., Song, Q., Yao, L., Tu, Y., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400055h · Cited by 163
Xia, H., Anderson, B., Mao, Q., & Davidson, B. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11359-11366.2000 · Cited by 162
Amin, F. U., Shah, S. A., Badshah, H., Khan, M., & Kim, M. O. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0227-4 · Cited by 161
Pandey, P. K., Sharma, A. K., & Gupta, U. D. (2015) · Tissue Barriers · doi:10.1080/21688370.2015.1129476 · Cited by 153
Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease
Schwab, C., Hosokawa, M., & McGeer, P. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.03.016 · Cited by 144
Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2
Yan, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00097 · Cited by 127
Jin, W., Shen, L., Bu, X., Zhang, W., Chen, S., Huang, Z., Xiong, J., Gao, C., Dong, Z., He, Y., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1721-y · Cited by 125
Ganugula, R., Arora, M., Jaisamut, P., Wiwattanapatapee, R., Jørgensen, H. G., Venkatpurwar, V. P., Zhou, B., Hoffmann, A. R., Basu, R., Guo, S., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13816 · Cited by 117
Liu, J., Xu, L., Liu, C., Zhang, D., Wang, S., Deng, Z., Lou, W., Xu, H., Bai, Q., & Ma, J. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.04.036 · Cited by 114
Self-citationDual-targeted polyplexes: One step towards a synthetic virus for cancer gene therapy
Nie, Y., Schaffert, D., Rödl, W., Ogris, M., Wagner, E., & Günther, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.028 · Cited by 106
Huang, H., Tang, D., Xu, K., & Jiang, Z.-F. (2013) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2013.848891 · Cited by 104
Zheng, K.-M., Dai, X., Xiao, N., Wu, X., Wei, Z., Fang, W., Zhu, Y., Zhang, J., & Chen, X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9802-9 · Cited by 103
Self-citationTDP-43 expression influences amyloidβ plaque deposition and tau aggregation
Davis, S. A., Gan, K. A., Dowell, J. A., Cairns, N. J., & Gitcho, M. A. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.012 · Cited by 101
Visser, C. C., Stevanović, S., Voorwinden, L. H., Gaillard, P. J., Crommelin, D. J. A., Danhof, M., & de Boer, A. G. (2004) · Journal of drug targeting · doi:10.1080/10611860410001701706 · Cited by 98
Curcumin Binds to Aβ1–40Peptides and Fibrils Stronger Than Ibuprofen and Naproxen
Ngô, S. T., & Li, M. S. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp302506a · Cited by 97
Pérez‐González, R., Pascual, C., Antequera, D., Bolós, M., Redondo, M., Pérez, D. I., Pérez‐Grijalba, V., Krzyzanowska, A., Sarasa, M., Gil, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.011 · Cited by 93
Zhang, L., Shen, C., Chu, J., Zhang, R., Li, Y., & Li, L. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.6232 · Cited by 92
Amyloid-β 42 Activates the Expression of BACE1 Through the JNK Pathway
Guglielmotto, M., Monteleone, D., Giliberto, L., Fornaro, M., Borghi, R., Tamagno, E., & Tabaton, M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110884 · Cited by 71
Paka, G. D., & Ramassamy, C. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00738 · Cited by 64
PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy
Fan, S., Zhang, B., Luan, P., Gu, B., Wan, Q., Huang, X., Liao, W., & Liu, J. (2015) · BioMed Research International · doi:10.1155/2015/161020 · Cited by 61
Self-citationProtective Effects of Curcumin on Amyloid-β-Induced Neuronal Oxidative Damage
Huang, H., Chang, P., Dai, X., & Jiang, Z.-F. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0754-9 · Cited by 54
Curcumin administration suppress acetylcholinesterase gene expression in cadmium treated rats
Akinyemi, A. J., Oboh, G., Fadaka, A. O., Olatunji, B. P., & Akomolafe, S. F. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.05.004 · Cited by 54
Liu, X., Mo, Y., Liu, X., Guo, R., Zhang, Y., Xue, W., Zhang, Y., Wang, C., & Ramakrishna, S. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.01.050 · Cited by 51
Self-citationAmyloid-β pathology induced in humans
Jucker, M., & Walker, L. C. (2015) · Nature · doi:10.1038/525193a · Cited by 47
Curcumin ameliorates insulin signalling pathway in brain of Alzheimer’s disease transgenic mice
Feng, H., Dang, H.-Z., Fan, H. J., Chen, X., Rao, Y., Ren, Y., Yang, J.-D., Shi, J., Wang, P., & Tian, J. (2016) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016659494 · Cited by 46
Self-citationChen, F., Ghosh, A., Wu, F., Tang, S., Hu, M. Y., Sun, H., Kong, L., & Hong, H. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.10.021 · Cited by 46
Urnauer, S., Klutz, K., Grünwald, G. K., Morys, S., Schwenk, N., Zach, C., Gildehaus, F., Rödl, W., Ogris, M., Wagner, E., et al. (2017) · The Journal of Gene Medicine · doi:10.1002/jgm.2957 · Cited by 20
Cited by
Yavarpour-Bali, H., Ghasemi-Kasman, M., & Pirzadeh, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s208332 · Cited by 364
Alsaab, H. O., Alharbi, F. D., Alhibs, A. S., Alanazi, N. B., Alshehri, B. Y., Saleh, M. A., Alshehri, F. S., Algarni, M. A., Almugaiteeb, T., Uddin, M. N., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122728 · Cited by 289
Formulations of Curcumin Nanoparticles for Brain Diseases
Del Prado-Audelo, M. L., Caballero-Florán, I. H., Meza-Toledo, J. A., Mendoza-Muñoz, N., González-Torres, M., Florán, B., Cortés, H., & Leyva-Gómez, G. (2019) · Biomolecules · doi:10.3390/biom9020056 · Cited by 191
“Finally, in a recent report, PLGA–PEG nanoparticles attached to the B6 peptide with curcumin encapsulated (PLGA/PEG-B6-Cur) were designed [108].”
BackgroundPoudel, P., & Park, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040835 · Cited by 124
Kim, M., Shin, M., Zhao, Y., Ghosh, M., & Son, Y. (2024) · Small Science · doi:10.1002/smsc.202400280 · Cited by 97
Metadata
- Authors
- Fan, S., Zheng, Y., Liu, X., Fang, W., Chen, X., Liao, W., Jing, X., Lei, M., Tao, E., Ma, Q., Zhang, X., Guo, R., & Liu, J.
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2018-01-01
- Volume
- 25
- Issue
- 1
- Pages
- 1091-1102
- ISSN
- 1071-7544 (ISSN-L)
- 1521-0464
- OpenAlex
- W2886328984
- Cited by
- 258
- References
- 61
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.